LS
BIIB icon

Leelyn Smith’s Biogen BIIB Stock Holding History

Leelyn Smith’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-35
Closed -$9.69K – 143
2022
Q4 		$9.69K Sell
35
-78
-69% -$22K ﹤0.01% 323
2022
Q3 		$30K Sell
113
-1,238
-92% -$263K 0.01% 189
2022
Q2 		$276K Sell
1,351
-8,620
-86% -$1.76M 0.07% 109
2022
Q1 		$2.1M Buy
9,971
+1,943
+24% +$423K 0.55% 56
2021
Q4 		$1.93M Buy
8,028
+78
+1% +$20.1K 0.52% 57
2021
Q3 		$2.25M Buy
7,950
+825
+12% +$270K 0.65% 43
2021
Q2 		$2.47M Sell
7,125
-436
-6% -$132K 0.73% 41
2021
Q1 		$2.12M Buy
7,561
+345
+5% +$93K 0.63% 45
2020
Q4 		$1.77M Buy
7,216
+681
+10% +$176K 0.57% 53
2020
Q3 		$1.85M Buy
6,535
+735
+13% +$205K 0.65% 40
2020
Q2 		$1.12M Buy
5,800
+627
+12% +$188K 0.46% 62
2020
Q1 		$1.64M Buy
5,173
+1,168
+29% +$354K 0.87% 27
2019
Q4 		$1.19M Buy
+4,005
New +$1.11M 0.57% 53

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Leelyn Smith's BIIB Position: Q1 2023 in Review

Leelyn Smith sold out of Biogen (BIIB) in Q1 2023, closing a stake of 35 shares — an estimated $9.69K sold.

Leelyn Smith first reported a position in BIIB in Q4 2019 and held it in 13 quarters. The position peaked at $2.47M in Q2 2021. 1,001 funds tracked by Wall St. Rank hold BIIB as of Q1 2023.

  • Leelyn Smith reported no remaining Biogen position as of Q1 2023 after selling out during the quarter.
  • Leelyn Smith sold 35 Biogen shares in Q1 2023, an estimated $9.69K.
  • Leelyn Smith first reported a position in Biogen in Q4 2019 and held it in 13 quarters.
  • Leelyn Smith's Biogen position peaked at $2.47M in Q2 2021.
  • 1,001 funds tracked by Wall St. Rank held Biogen as of Q1 2023.

Based on Leelyn Smith's 13F filing for Q1 2023, filed 12 May 2023.